M

MBX Biosciences Inc
NASDAQ:MBX

Watchlist Manager
MBX Biosciences Inc
NASDAQ:MBX
Watchlist
Price: 12.47 USD 1.14% Market Closed
Market Cap: 416.7m USD

Intrinsic Value

MBX's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one MBX stock under the Base Case scenario is 7.84 USD. Compared to the current market price of 12.47 USD, MBX Biosciences Inc is Overvalued by 37%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MBX Intrinsic Value
7.84 USD
Overvaluation 37%
Intrinsic Value
Price
M
Worst Case
Base Case
Best Case
Compare MBX to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about MBX?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about MBX Biosciences Inc
Financials
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
MBX Biosciences Inc

Balance Sheet Decomposition
MBX Biosciences Inc

Current Assets 244.3m
Cash & Short-Term Investments 240.8m
Receivables 1.4m
Other Current Assets 2.1m
Non-Current Assets 1.7m
PP&E 1.6m
Other Non-Current Assets 50k
Efficiency

Free Cash Flow Analysis
MBX Biosciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
MBX Biosciences Inc

Revenue
0 USD
Operating Expenses
-81.4m USD
Operating Income
-81.4m USD
Other Expenses
7.9m USD
Net Income
-73.5m USD
Fundamental Scores

MBX Profitability Score
Profitability Due Diligence

MBX Biosciences Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
Negative ROE
26/100
Profitability
Score

MBX Biosciences Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

MBX Solvency Score
Solvency Due Diligence

MBX Biosciences Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

MBX Biosciences Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MBX Price Targets Summary
MBX Biosciences Inc

Wall Street analysts forecast MBX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MBX is 38.15 USD with a low forecast of 30.3 USD and a high forecast of 46.2 USD.

Lowest
Price Target
30.3 USD
143% Upside
Average
Price Target
38.15 USD
206% Upside
Highest
Price Target
46.2 USD
270% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

MBX Biosciences Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for MBX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

MBX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one MBX stock?

The intrinsic value of one MBX stock under the Base Case scenario is 7.84 USD.

Is MBX stock undervalued or overvalued?

Compared to the current market price of 12.47 USD, MBX Biosciences Inc is Overvalued by 37%.

Back to Top